The short version of PPARδ agonist fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-18. Anything still debated is marked as such rather than presented as settled.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
| Property | Value | Notes |
|---|---|---|
| Solubility | Soluble in dimethyl sulfoxide and some organic solvents; practically insoluble in water | Solvent choice affects laboratory handling |
| Typical storage | -20 °C, desiccated, protected from light | Common condition for research samples |
| Analytical method | Liquid chromatography–tandem mass spectrometry (LC-MS/MS) | Used for identification and quantification in biological or product samples |
| Common synonyms | GW501516, GW-501516, GSK-516, Endurobol | Names found in research and anti-doping literature |
| Regulatory status | Unapproved therapeutic; prohibited in competitive sport | Status can vary by country and context |
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
BLAST is an algorithm for comparing biomacromolecule primary structure, most often nucleotide sequence of DNA/RN, and amino acid sequence of proteins, stored in the bioinformatic databases, with the query sequence. The algorithm uses scoring of the available sequences against the query by a scoring matrix such as BLOSUM 62. The highest scoring sequences represent the closest relatives of the query, in terms of functional and evolutionary similarity. The database search by BLAST requires input data to be in a correct format (e.g. FASTA, GenBank, PIR or EMBL format). Users may also designate the specific databases to be searched, select scoring matrices to be used and other parameters prior to the tool run. The best hits in the BLAST results are ordered according to their calculated E-value (the probability of the presence of a similarly or higher-scoring hit in the database by chance).
=== Counter-Strike: Malvinas === Counter-Strike: Malvinas is a custom Counter-Strike: Source map, developed and distributed by Argentine web hosting company Dattatec. The map was released worldwide on 4 March 2013. The game is set in Stanley, the capital of the Falkland Islands, and revolves around a group of Argentine special forces (portrayed as the counter-terrorist team) capturing the archipelago from British Royal Marines, who are portrayed as terrorists. The map is inspired by the 1982 Falklands War, in which an estimated 650 Argentine and 255 British servicemen died. The mod prompted strong controversy in the United Kingdom; Dattatec's website was targeted by British hackers on 27 March 2013.
=== Dosage units === One international unit of insulin (1 IU) is defined as the "biological equivalent" of 34.7 μg pure crystalline insulin. The first definition of a unit of insulin was the amount required to induce hypoglycemia in a rabbit. This was set by James Collip at the University of Toronto in 1922. Of course, this was dependent on the size and diet of the rabbits. The unit of insulin was set by the insulin committee at the University of Toronto. The unit evolved eventually to the old USP insulin unit, where one unit (U) of insulin was set equal to the amount of insulin required to reduce the concentration of blood glucose in a fasting rabbit to 45 m g/d L (2.5 m mol/L). Once the chemical structure and mass of insulin was known, the unit of insulin was defined by the mass of pure crystalline insulin required to obtain the USP unit. The unit of measurement used in insulin therapy is not part of the International System of Units (abbreviated SI) which is the modern form of the metric system. Instead the pharmacological international unit (IU) is defined by the WHO Expert Committee on Biological Standardization.
==== October-November 2008 ==== In October 2008, Duel reported that soldier Maksim Pasko, who died near Gori on 12 August, had sent several SMSes. One SMS was sent on 3 August 2008 and said: "Don't worry too much, the Georgian militants are battering Tskhinvali. We were given orders to go there." Another SMS, sent on 5 August 2008, said: "Yesterday, our artillerists were messing with Georgia. 22 were killed and 150 injured." It was also reported that Russian military transport aircraft and attack helicopters began flying in the airspace of Abkhazia since 5 August 2008. Maksim Pasko had served in the 693rd Regiment. In October 2008, Russian military officer told Zavtra that at about 03:00 AM on 8 August, his division commander called him. He also said, "We took prisoners and they told us that after our break and the battle at a military base, a rumor spread that two Russian divisions had invaded Georgia and were sweeping everything in their path, and were slaughtering everyone without mercy." In October 2008, Sovershenno Sekretno newspaper reported that the 135th Motorized Rifle Regiment of the 58th Army received the order to move towards Tskhinvali a few hours before the Georgian attack.
Sources: en.wikipedia.org
=== Localized and overall support === Fabric may be used to provide support for the garment by stabilizing weak sections or by creating a backing or lining for the piece. Darning may be utilized on coarsely-woven fabrics with localized areas of damage.
== Presence == In cephalochordates (lancelets), the notochord persists throughout life as the main structural support of the body. In tunicates, the notochord is present only in the larval stage, becoming completely absent in the adult animal, and the notochord is not vacuolated. In all vertebrates other than the hagfish, the notochord is present only during early embryonic development and is later replaced by the bony and/or cartilaginous vertebral column, with its original structure being integrated into the intervertebral discs as the nucleus pulposus.
== Ownership and finance == Marks and Hazan initially supported GYG with their own money. In 2009, they sold a minority stake to Peter Ritchie, Guy Russo and Steve Jermyn, who had previously been involved with McDonald's Australia. Russo was subsequently appointed chairman of the board. The board also includes co-founder Robert Hazan, Tom Cowan of TDM Growth Partners, Rokt CEO Bruce Buchanan, and three former McDonalds executives. Investment firm TDM Growth Partners bought a stake in the company for $44 million in August 2018. In December 2020, the publicly listed Magellan Financial Group bought 10% of the company for $86.8 million. In May 2022, Magellan sold its 11.6% stake in the company to an entity owned by investment bank Barrenjoey Capital Partners for $140 million. Marks stated in 2019 that his goal was to list GYG on the Australian Securities Exchange. In 2020, he stated that he was also ambitious to expand the company's presence in the United States, citing Australia's "antiquated" labour laws, high rents, and expensive fresh produce. Marks resigned as CEO due to a health scare in May 2023, but he changed his mind and remained. Hilton Brett was appointed co-CEO in October 2023. GYG was listed on the Australian Securities Exchange on 20 June 2024.
Sources: en.wikipedia.org
At least since King Otto I of Germany had conquered the former Lombard Kingdom of Italy in 961 and had himself crowned Holy Roman emperor in Rome, the principal passes of the Eastern Alps had become an important transit area. The German monarchs regularly traveled across the Brenner or Reschen Pass on their Italian expeditions aiming at papal coronation or the consolidation of Imperial rule. In 1004 King Henry II of Germany separated the estates of Trent from the North Italian March of Verona and vested the bishops of Trent with comital rights. In 1027 Henry's Salian successor, Emperor Conrad II, granted the Trent bishops further estates around Bozen and in the Vinschgau region; at the same time, he vested the bishop of Brixen with the suzerainty in the Etschtal and Inntal, part of the German stem duchy of Bavaria under the rule of Conrad's son Henry III. Especially the Brixen bishops remained loyal supporters of the Salian rulers in the Investiture Controversy and in 1091 also received the Puster Valley from the hands of Emperor Henry IV.
Polysaccharides containing alpha-(1-4)-linked D-glucose units + H2O (specific for alpha-(1-4)-linkages, requirements for non-reducing chain end) Starch + H2O Amylopectin + H2O Glycogen Amylose + H2O Alpha-D-glucopyranosyl-(1-4)-2-deoxy-D-glucal (maltal) Inhibitors include Glucose, Maltose (competitive), Alpha-methyl-glucoside, Cyclodextrins (e.g. cyclohexaamylose), o-Iodosobenzoate, Ag+, Hg2+, Cu2+, N-Ethylmaleimide, p-Chloromercuribenzoate (reversed by DTT or mercaptoethanol, reversed by glutathione), Pb2+, Ni2+, Cd2+, Fe3+, Zn2+, Mn2+, Mg2+, EDTA, Beta-amylase inhibitor (from Streptomyces sp. No. 54), K2PtCl6, K2PtCl4, K2IrCl6, Na2PdCl6, CO32-, and Iodoacetamide.
== Analysis == HCPs are identified during the manufacturing of biopharmaceuticals as part of the quality control process. During the production process several factors, including the genes of the host cell, the way of product expression and the purification steps, influence the final HCP composition and abundance. Several studies report that HCPs are often co-purified along with the product itself by interacting with the recombinant protein. Enzyme linked immunosorbent assay (ELISA) is the predominant method for HCP analysis in pharmaceutical products due to its high sensitivity to proteins, which allows it to detect the low levels of HCPs in produced drugs. Even though the developmental process requires an extended period of work and several tests with animal models, analysis of HCP content in the final product can be rapidly performed and interpreted. Whilst ELISA possesses the sensitivity to undergo HCP analysis, several limitations are associated with the procedure. The HCP quantification relies mainly on the quantity and affinity of anti-HCP antibodies for detection of the HCP antigens. Anti-HCP antibody pools cannot cover the entire HCP population and weakly immunogenic proteins are impossible to detect, since equivalent antibodies are not generated in the process. In addition, methods such as the combination of mass spectrometry (MS) and liquid chromatography (LC-MS) have been developed to allow for more efficient and effective HCP analysis and purification. These methods are able to:
Sources: en.wikipedia.org
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.
No. It is not an anabolic-androgenic steroid; it is a synthetic PPARδ agonist. Because it is banned in sport, it is sometimes grouped with doping agents even though its chemical class differs from steroids.
Human data are limited and development was discontinued, so major effects and long-term risks are not well characterized. Some early studies examined metabolic markers, but they do not provide a basis for unsupervised use.
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.